|
Volumn 23, Issue 1, 2008, Pages 420-
|
Phosphate binders and timing of levothyroxine administration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM HYDROXIDE;
AMLODIPINE;
CALCIUM CARBONATE;
ENALAPRIL;
ESOMEPRAZOLE;
LEVOTHYROXINE;
PARACETAMOL;
PHOSPHATE BINDING AGENT;
SEVELAMER;
THYROTROPIN;
VITAMIN B GROUP;
CHELATING AGENT;
PHOSPHATE;
POLYAMINE;
THYROXINE;
ADULT;
ARTERIOVENOUS FISTULA;
CASE REPORT;
DRUG ABSORPTION;
DRUG DOSE INCREASE;
FEMALE;
HEMODIALYSIS PATIENT;
HUMAN;
HYPOTHYROIDISM;
INTERSTITIAL NEPHRITIS;
LETTER;
MEDLINE;
PRIORITY JOURNAL;
THYROTROPIN BLOOD LEVEL;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
DRUG INTERACTION;
METABOLISM;
MIDDLE AGED;
CHELATING AGENTS;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
HYPOTHYROIDISM;
MIDDLE AGED;
PHOSPHATES;
POLYAMINES;
THYROXINE;
|
EID: 44449129464
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfm615 Document Type: Letter |
Times cited : (14)
|
References (3)
|